STOMSCAPE, a premier manufacturer of oral regenerative biomaterials, officially announces the international availability of its flagship BellaOss™ Bone Graft series for private labeling (OEM/ODM).
Engineered for highly predictable bone regeneration, the advanced xenograft bone substitute features a highly interconnected macro- and micro-porous structure that optimizes osteoconduction and angiogenesis. Fully compliant with rigorous global regulatory frameworks, the premium bone graft offers international dental brands an elite, market-ready portfolio expansion.
Partner with STOMSCAPE to access customizable packaging, comprehensive technical documentation, and scalable global trade compliance.